Search

Latest News

The Complexities of Pharmaceutical Distribution

  Distribution in the pharmaceutical industry is far more complex than many other sectors, given the sensitive nature of the products involved. Pharmaceutical companies must manage regulatory compliance, ensure product…

Learn More

IMP Supply for EU Clinical Trials

Investigational Medicinal Products (IMPs) to be used in an EU clinical trial must be certified by a Qualified Person (QP) named on a Manufacturing and Import Authorisation (MIA(IMP)) to ensure…

Learn More

The QP Oversight Process

The MHRA introduced the QP Oversight process for clinical supplies entering into Great Britain from the EU/EEA after Brexit. The Medicines for Human Use (Clinical Trial) Regulations 2004 requires that…

Learn More

Challenges of Clinical Secondary Packaging and Labelling 

  Secondary packaging and labelling of clinical trial material present unique challenges due to regulatory requirements, patient safety concerns, and logistical complexities. Navigating these challenges requires a comprehensive understanding of…

Learn More

IMP Supply for UK Clinical Trials

Investigational Medicinal Products (IMPs) to be used in a UK clinical trial must be certified by a Qualified Person (QP) named on a Manufacturing and Import Authorisation (MIA(IMP)) to ensure…

Learn More

IMP Supply for EU Clinical Trials

Investigational Medicinal Products (IMPs) to be used in an EU clinical trial must be certified by a Qualified Person (QP) named on a Manufacturing and Import Authorisation (MIA(IMP)) to ensure…

Learn More

The UK QP oversight process for Investigational Medicinal Products

What is the UK QP oversight process for Investigational Medicinal Products? Sponsors of a UK clinical trial using IMPs imported into Great Britain from countries on an ‘approved country for…

Learn More

PNR Pharma expands its in-house capabilities with the addition of a UK-based warehouse

PNR are delighted to announce the MHRA approval of our new facility in Blaenau Gwent, South Wales.  We hold MIA, MIA(IMP), MS and WDA licences which allow us to expand…

Learn More

QP Declaration in Clinical Trials

Qualified Person (QP) Declaration in Clinical Trials. When developing a new drug, it is critical to ensure that it is safe and effective for use in humans. Clinical trials are…

Learn More

Welcome to PNR, Tony Pinney!

We are delighted to welcome Tony Pinney to PNR Pharma as Qualified Person. Tony has over 30 years’ experience within the Pharmaceutical Industry with various roles within Quality. After qualifying as a QP…

Learn More

Let us tell you more

We will email you to start the conversation